NZ222226A - Liquid sanitising/cleaning compositions with quaternary ammonium, benzoate and nonionic surfactants - Google Patents
Liquid sanitising/cleaning compositions with quaternary ammonium, benzoate and nonionic surfactantsInfo
- Publication number
- NZ222226A NZ222226A NZ22222687A NZ22222687A NZ222226A NZ 222226 A NZ222226 A NZ 222226A NZ 22222687 A NZ22222687 A NZ 22222687A NZ 22222687 A NZ22222687 A NZ 22222687A NZ 222226 A NZ222226 A NZ 222226A
- Authority
- NZ
- New Zealand
- Prior art keywords
- quaternary ammonium
- alkyl
- benzoate
- formula
- halide
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 49
- 239000002736 nonionic surfactant Substances 0.000 title claims description 17
- 125000001453 quaternary ammonium group Chemical group 0.000 title claims description 16
- 238000004140 cleaning Methods 0.000 title claims description 10
- 239000007788 liquid Substances 0.000 title claims description 8
- -1 quaternary ammonium halide Chemical class 0.000 claims description 45
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 238000012360 testing method Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 229940090948 ammonium benzoate Drugs 0.000 claims description 12
- 238000009472 formulation Methods 0.000 claims description 12
- 229910052783 alkali metal Inorganic materials 0.000 claims description 11
- 150000004820 halides Chemical class 0.000 claims description 9
- 238000011012 sanitization Methods 0.000 claims description 9
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 8
- 235000010234 sodium benzoate Nutrition 0.000 claims description 8
- 239000004299 sodium benzoate Substances 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 7
- 206010030113 Oedema Diseases 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 239000003205 fragrance Substances 0.000 claims description 6
- 230000007794 irritation Effects 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 claims description 3
- 230000002500 effect on skin Effects 0.000 claims description 2
- RODZIAKMFCIGPL-UHFFFAOYSA-N P.I.I Chemical compound P.I.I RODZIAKMFCIGPL-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 10
- 206010015150 Erythema Diseases 0.000 description 8
- 231100000321 erythema Toxicity 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- KWIPUXXIFQQMKN-UHFFFAOYSA-N 2-azaniumyl-3-(4-cyanophenyl)propanoate Chemical compound OC(=O)C(N)CC1=CC=C(C#N)C=C1 KWIPUXXIFQQMKN-UHFFFAOYSA-N 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 3
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 230000003292 diminished effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- HNLXNOZHXNSSPN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 HNLXNOZHXNSSPN-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 125000006177 alkyl benzyl group Chemical group 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 239000007970 homogeneous dispersion Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- KUXGUCNZFCVULO-UHFFFAOYSA-N 2-(4-nonylphenoxy)ethanol Chemical class CCCCCCCCCC1=CC=C(OCCO)C=C1 KUXGUCNZFCVULO-UHFFFAOYSA-N 0.000 description 1
- ATBQNLZREVOGBO-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 ATBQNLZREVOGBO-UHFFFAOYSA-N 0.000 description 1
- XXPRRHYTDCWGRP-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 XXPRRHYTDCWGRP-UHFFFAOYSA-N 0.000 description 1
- BPZYKPINOMFZGY-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)c1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1 BPZYKPINOMFZGY-UHFFFAOYSA-N 0.000 description 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000949477 Toona ciliata Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- SHMACWZVEQYCFA-UHFFFAOYSA-N benzyl(14-methylpentadecyl)azanium;chloride Chemical compound [Cl-].CC(C)CCCCCCCCCCCCC[NH2+]CC1=CC=CC=C1 SHMACWZVEQYCFA-UHFFFAOYSA-N 0.000 description 1
- OCBHHZMJRVXXQK-UHFFFAOYSA-M benzyl-dimethyl-tetradecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 OCBHHZMJRVXXQK-UHFFFAOYSA-M 0.000 description 1
- LRJXMBUKFFUEQS-UHFFFAOYSA-N benzyl-dodecyl-dimethylazanium;cyanide Chemical compound N#[C-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 LRJXMBUKFFUEQS-UHFFFAOYSA-N 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- SCXCDVTWABNWLW-UHFFFAOYSA-M decyl-dimethyl-octylazanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCC SCXCDVTWABNWLW-UHFFFAOYSA-M 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000006182 dimethyl benzyl group Chemical group 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical class [H]C([H])([H])* 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 229920000847 nonoxynol Polymers 0.000 description 1
- 229940078482 nonoxynol-8 Drugs 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 229920004905 octoxynol-10 Polymers 0.000 description 1
- 229920004908 octoxynol-13 Polymers 0.000 description 1
- 229920004903 octoxynol-7 Polymers 0.000 description 1
- LPNBBFKOUUSUDB-UHFFFAOYSA-N p-toluic acid Chemical compound CC1=CC=C(C(O)=O)C=C1 LPNBBFKOUUSUDB-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000000837 restrainer Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Description
New Zealand Paient Spedficaiion for Paient Number £22226
222 226
Priority D.
/ /■ t
/W '/V^ ?/ C /-c ■ V /' ■/,
- t9 JAN toon
Z(
NEW ZEALAND PATENTS ACT. 1953
OCT 1937
No.: Date:
COMPLETE SPECIFICATION
LIQUID SANITIZING AND CLEANING COMPOSITION
STERLING DRUG INC., incorporated in the State of Delaware, U.S.A., of 90 Park Avenue, New York, State of New York, United States of America,
hereby declare the invention for which*!—/ we pray that a patent may be granted to sad\is, and the method by which it is to be performed, to be particularly described in and by the following statement: -
(followed by page la)
222226
—lo
This invention relates to quaternary aaaonium salt-containing liquid sanitizing and cleaning compositions having diminished sJcin irritancy.
Quaternary ammonium salts, particularly quaternary ammonium salts of the di-(lower-alky1)-long-chain-alkyl-benzylammonium halide and the di-(lower-alky1)-di-(long-chain-alky1)ammonium halide types, are of course well known in the prior art as is the use of such quaternary ammonium halides, either alone or in combination with surfactants, in bactericidal applications, such as in sanitizing and cleaning compositions.
French Patent No. 2,458,280 discloses compositions for removing make-up from the eyes comprising an aqueous solution of at least one surfactant selected from polyethoxylated esters of Cl2"-Ci8 fatty acids and glycerol, at least one preservative selected from a group of four which includes a mixture of 3 0% sodium benzoate and 7 0% monochloracetamide, a dimethylbenzylalkylammonium chloride and a phosphate buffer, the compositions having a pH of 6.5 - 7.5. The reference specifically discloses "myristyl cetyl dimethyl benzyl ammonium" chloride as a quaternary. The compositions are stated not to sting or irritate.
C -8DEC1989
1
222 2 26
Japanese Patent Document No. 58/76579, published May 9, 1983 [abstracted at Derwent Japanese Patents Gazette, page 16, Sect. D, Week K24, 1983], discloses a deodorant for feathers containing a quaternary ammonium or 5 alkyl pyridinium salt type cationic surfactant and an organic carboxylic acid in the ratio of 1:9 to 9:1. The quaternary ammonium salt is selected from a group of five classes, including a dimethylbenzyl (Cg-C22)-alkylammonium halide, where alkyl is, for example, lauryl, myristyl or 10 cetyl; and the organic carboxylic acid is selected from a group of ten, including benzoic acids.
•
Japanese Patent Document No. 57/106612, published July 2, 1982 [abstracted at Derwent Japanese Patents-Gazette, page 3, Sect. B, Week E32, 1982], discloses a 15 turbidity-free eye lotion prepared by adding a water-soluble salt (0.02-0.3 w/v%) to an eye lotion comprising a glycyrrhizinic acid salt (0.02-0.2 w/v%) and a cationic surfactant (0.002-0.02 w/v%). As water soluble salt and cationic surfactant there are disclosed, inter alia, sodium 20 benzoate and benzalkonium chloride, respectively. The eye lotion is stated to cause little irritation to the eyes.
U.S. Patent 3,361,794 discloses microbiologically active "relatively water insoluble" quaternary ammonium compounds
having the formula [R^^fCHg)2]+[RZCOO]~ where: "R' is an alkyl radical containing from 8 to 22 carbon atoms, an
< •
alkyl benzyl radical in which the benzyl group may contain a substituent methyl radical and in which the alkyl group contains 8 to 22 carbon atoms, or an alkyl phenoxy ethoxy 30 ethyl radical in which the phenyl group may contain a
22 2 2 2
substituent methyl radical and R" is a benzyl or substituted benzyl radical, or a methyl group if R' is an alkyl benzyl radical containing eight or more carbon atoms in its alkyl substituent". The compounds are prepared by 5 reaction of the corresponding quaternary ammonium hydroxides or water-soluble salts with a carboxylic acid, RZCC^H, where "R is a mono- or poly-alkyl substituted benzene or naphthalene nucleus, or the substituted nucleus of diphenyl or diphenyl oxide in each of which cases the 10 substituents may be radicals having from 1 to 22 carbon atoms, and 2 is (CH^)n or (CH2)n~2H where n is any number" from zero to four", Specific compounds disclosed include-alkyl- (50% C^/ 30% C^, 17% 3% C^g) dimethylbenzyl-
ammonium p-(and m-) toluate. The compounds are disclosed 15 to be especially appropriate for a wide variety of specifically identified applications, including application as additives for anionic and nonionic detergents in liquid and solution form.
U.S. Patent 2,108,765 discloses 20 quaternary ammonium compounds having at least one high molecular weight aliphatic hydrocarbon radical as the substituent on the nitrogen atom and having bactericidal and fungicidal properties. Among compounds specifically enumerated are dimethyldecylbenzylanunonium 25 chloride, dimethyldodecylbenzylammonium cyanide and dimethyltridecylbenzylammonium chloride. It is stated that other salts may be employed, including benzoates, but no quaternary ammonium benzoates are either specifically named or exemplified. It is also stated that the compo-30 sitions used for disinfection "do not injure the skin and
222226
«p—
therefore may also be used for the disinfection of the skin, particularly the hands".
Brady et al. , J. Am. Chera. Soc. 106, 4279-4280 (1984) disclose a study of the effects of a variety of 5 didodecyldimethylammonium carboxylate salts, including the benzoate, as surfactants to promote the spontaneous formation of lipid vesicles.
Campanella et al., Rev. Roum. Chim. ^7(5), 681-683 (1982) [Chem. Abstr., 98, 83039s (1983)] discloses a 10 liquid membrane electrode for benzoic acid determination-containing dimethyld icetylammoniuni benzoate and benzyl-dime thylcetylanunonium benzoate.
We have surprisingly found that use of certain quaternary ammonium benzoates in aqueous sanitizing and 15 cleaning compositions containing a nonionic surfactant have greatly diminished skin irritancy as compared with compositions containing the corresponding quaternary ammonium halides.
More specifically, the invention re-
sices in liquid sanitizing and cleaning compositions comprising a di-(lower-alkyl)-long-chain-alky1-benzylammonium benzoate and/or a di-(lower-alkyl)-di-(long-chain-alkyl)ammonium benzoate in combination with a 25 nonionic surfactant of the straight chain alkylethoxylate, secondary alkylethoxylate or alkylphenolethoxylate classes
A. •
in water.
22 2 2
r
In accordance with the foregoing, the sanitizing and cleaning compositions of the invention comprise: (A) a quaternary ammonium benzoate of the formula:
where R^ and R2 are lower-alkyl groups containing from 1 to 3 carbon atoms; R^ is R4 ^8-^*16
alkyl or benzyl; and X is the benzoate anion; (B) a non-. ionic surfactant which is an alkylphenolethoxvlate of the' formula:
where R is Cg-Cg alkyl, and x is an integer from 7 to 13 and indicates the average number of (OCf^CI^) units in the side chain, or a straight-chain alkylethoxylate or a secondary alkylethoxylate of the formula:
X
I
II
22 2 2 2 6
H"(OCH CH J 0R a n a
III
where R$ is ci4~ci5 alkyl and n is an integer from 7 to 13; and (C) water.
The di-(lower-alkyl)-long-chain-alkylbenzylammonium 5 benzoates or di-(lower-alkyl)-di-(long-chain-alkyl)ammonium benzoates of formula I can be prepared by ion exchange with the corresponding quaternary ammonium halide (X- is halide). However, the preparation of the quaternary ammonium benzoate _in situ by addition to an aqueous solu-10 tion of the quaternary ammonium halide of about one molar-equivalent of an alkali metal benzoate per mole of quater-'
nary ammonium halide is economically more feasible, and accordingly, in a preferred method, the compositions are prepared, in accordance with a process to be described 15 hereinafter, by mixing aqueous solutions of the quaternary ammonium halide and an alkali metal benzoate to produce the quaternary ammonium benzoate i_n situ.
Accordingly, the compositions of the invention can also be defined as comprising: (A) a di-(lower-alkyl)-20 long-chain-alkylbenzylammonium halide or a di-(lower-alkyl)-di-(long-chain-alkyl)ammonium halide of formula I,
where X is halide; (B) a nonionic surfactant which is an alkylphenolethoxylate of formula II or a straight — chain alkylethoxylate or second-
ary alkylethoxylate of formula III supra; (C) water; and (D) from about one to about two molar equivalents of an alkali metal benzoate relative to the quaternary ammonium halide. While a larger excess above about two molar equivalents of benzoate may be added, no particular advan-30 tage is gained thereby.
22 2 2
The di-(lower-alkyl)-long-chain-alkylbenzylammonium halides and the di-(lower-alkyl)-di-(long-chain-alkyl)-ammonium halides of formula I where X~ is halide used to prepare the quaternary ammonium benzoates of the compo-5 sitions are well known classes of compounds. The di-(lower-alkyl)-long-chain-alkylbenzylammonium halides include, for example, benzalkonium chloride (dimethyl-alkylbenzylamraonium chloride) sold under the trade name CYNCAL* 80% by The Hilton-Davis Chemical Company, 10 Cincinnati, Ohio, which consists of 80% by weight of alkyl-dimethylbenzylanunonium chloride (50% 40% C^ and 10
Clg alkyl), 10% water and 10% ethanol, and myristalkoniunf chloride (dimethylmyristylbenzylammonium chloride), sold under the trade name BARQUAT* MS-10 0 by Lonza Inc., 15 Fairlawn, New Jersey.
The di-(lower-alkyl)-di-(long-chain-alkyl)ammonium halides of formula I above, where R^ and Rj are lower-alkyl, R^ and R4 are both Cg-Clg alkyl and X~ is halide, include, for example, decyldimethyloctylammonium chloride, 20 didecyldimethylammonium chloride and dimethyldihydro-genated tallow ammonium chloride, sold under the trade names BARDAC* 2050, BARDAC* 2250 and CAROSOFT® 18, respectively, by Lonza Inc.
The alkylphenolethoxylates of formula II are also 25 well known in commerce, examples thereof being sold under the Rohm and Haas (Philadelphia, Pennsylvania) trade names TRITON* X and TRITON* N or the GAF Corporation (Wayne, New Jersey) trade names IGEPAL* CA and IGEPAL* CO,, and are identified by the CTFA adopted names of octoxynols and 30 nonoxynols. These include, for example, octoxynol-7,
22 2 2 2
octoxynol-10 and octoxynol-13 where R in formula II is CH^C(CH^)2CH2C(CH3)2~ and x has an average value of 7, 10 and 13, respectively, and nonoxynol-7, nonoxynol-8, nonoxynol-13, etc., where R in formula II is and *
has an average value of 7, 8 and 13 respectively.
The straight-chain alkylethoxylates and secondary alkylethoxylates of formula III above are also commercially available. Examples thereof are sold under the Shell Chemical Company (Houston, Texas) trade name NEODOL* 45 and 10 are identified by the CTFA adopted name, pareth-45.
Suitable members of the group for the practice of the m
present invention are pareth-45-7, pareth-45-11 and
* r pareth-45-13, where R^ in formula III is the residue of a" mixture of synthetic C^-C^ alcohols and n has an average 15 value of 7, 11 and 13 respectively.
As indicated above, the compositions of the invention can be prepared by use of di-(lower-alkyl)-long-chain-alkylbenzylammonium benzoates or di-(lower-alkyl)-di-(long-chain-alkyl)ammonium benzoates per se (X~ in formula 20 I is the benzoate anion). When so-formulated, the amounts of the quaternary ammonium benzoate of formula I and the nonionic surfactant of formulas II or III are in the range from 1 to 10 weight percent for the quaternary and from 10 to 20 weight percent for the nonionic surfactant, all 25 amounts being based on the total weight of the composition. The compositions so-formulated can also contain an additional amount up to about 7 weight percent of an alkali metal benzoate so as to provide a total up to about 2 molar equivalents of benzoate relative to the quaternary 30 ammonium cation. Preferred ranges are from about 4 to 10 weight percent for the quaternary and from 12 to 17 weight
22 2 2 26
percent for the nonionic surfactant, and particularly preferred amounts are about 6.4 weight percent of quaternary and about 12 weight percent of the nonionic surfactant.
Alternatively, and preferably, the compositions are prepared by forming the di-(lower-alkyl)-long-chain-alkylbenzylammonium benzoate or the di-(lower-alkyl)-di-(long-chaii—alkyl) ammonium benzoate i_n situ by dissolving the corresponding quaternary ammonium halide and lo alkali metal benzoate in water. When so-formulated, it is necessary to add about one molar equivalent of an alkali metal benzoate per mole of quaternary halide. Compositions
0
containing about a 1:1 molar equivalent ratio of alkali
metal benzoate:quaternary ammonium halide show particu-15 larly good diminution in skin irritancy, but optimal diminution is obtained at a molar equivalent ratio of these ingredients around 2:1, and such ratio is particularly preferred.
When the compositions are prepared by formation of 20 the quaternary ammonium benzoate in situ, the amounts of the quaternary ammonium halide and the nonionic surfactant used are from about 1 to 10 weight percent of the quaternary ammonium halide and from about 10 to 20 weight percent of the nonionic surfactant, preferred amounts being about 4 25 to 10 weight percent of quaternary and about 12 to 17 weight percent of the nonionic surfactant, and particularly preferred amounts being about 6.4 weight percent of the quaternary and about 12 weight percent of the nonionic surfactant. Sufficient alkali metal benzoate is then added 30 to provide a molar equivalent ratio of the benzoate to the
22 2 2
quaternary of from about 1:1 to about 2:1. A particularly preferred composition within the ambit of the invention comprises about 4.0 weight percent sodium benzoate, about 8.0 weight percent CYNCAL 80* corresponding to 6.4 weight 5 percent of actives, about 12 weight percent NEODOL* 45-7 (pareth-45-7) and the balance water.
The compositions may, in order to provide additional benefits, optionally contain non-essential ingredients such as fragrances, dyes, brighteners, other solvents such 10 as ethanol or thickeners. Generally, fragrances may be used in amounts up to about 1.0 weight percent, dyes in amounts up to about 0.01 weight percent; brighteners in . amounts up to about 0.6 weight percent; ethanol in amounts' up to about 10 weight percent; and thickeners in amounts up 15 to about 2.0 weight percent.
When the compositions are formulated from the quaternary ammonium benzoates, they may conveniently be prepared by sequential addition to water, with stirring at ambient temperature, of the nonionic surfactant, followed 20 by the quaternary ammonium benzoate, followed by the dyes, fragrances, brighteners, solvent or thickeners, stirring being continued at each stage to effect either complete solution or homogeneous dispersion of each ingredient. When they are formulated by preparation of the quaternary 25 ammonium benzoate jji situ, they may conveniently be prepared by sequential addition to water, with stirring at ambient temperature, first of the sodium benzoate, followed by the nonionic surfactant, followed by the quaternary ammonium halide, followed by the dyes, fragrances, 30 brighteners, solvent and thickeners, stirring being continued, as before, at each stage to effect either complete solution or homogeneous dispersion of each ingredient.
ft*:
22 2 2
The compositions of the invention, with their diminished skin irritancy, are particularly valuable in household sanitizing and cleaning operations where the unprotected hands may be subjected to prolonged exposure 5 for an extended period of time. They are thus particularly useful as laundry detergents and as hard surface cleaners.
The manner and process of making and using the invention, and the best mode contemplated by the inventor for carrying out the invention, will now be described 10 so as to enable any person skilled in the art to which it pertains to make and to use the same.
m
EXAMPLES
Three formulations composed as follows, and prepared as described above, were prepared for test purposes:
Formulation (Amounts in 15 wt-%; Moles in parentheses*)
ABC
CYNCAL* (80% active) 8.0(0.018) 8.0(0.018) 8.0
Sodium benzoate 4.0(0.028) 2.0(0.014)
NEODOL* 45-7 12.0 12.0 12.0
Bal. H20, fragrance q.s. q.s. q.s.
dye, brightener
*Moles of CYNCAL based on average molecular weight of 359.
.Formulations A and B are formulated in accordance with the invention as described above and are within the ambit of the invention , whereas Formulation C was prepared for comparative purposes and is outside the scope of the 25 invention. *-
Each of Formulations A, B and C, prepared as described above, was tested for skin irritancy in accordance with EPA protocols as follows:
222226
Groups of New Zealand white rabbits of either sex weighing approximately 2 kg and about 3 months of age were used for each test formulation, 6 rabbits per group. Test animals, after being checked for good health, were maintained in steel cages and allowed food and water ad libitum for a period of 4 days prior to testing. All animals were checked once again for good health 24 hours prior to testing, and any animals in poor condition, and particularly animals with skin eruptions or dermal lesions, were rejected from the test group. They were then prepared for testing by close clipping the skin of the mid-dorsal r
area of the trunk between the scapulae and the pelvis p using a small animal clipper. Immediately prior to test initiation, the animals were placed in wooden restrainers, and 4 test sites, each 2.5 cm , were chosen two on each side of the vertebral column, in opposite corners of the clipped area. All sites were maintained intact during the test procedure. A single application of 0.5 ml of each test formulation was introduced to each test site under a
2
2.5_cm gauze pad, and the gauze pad was fixed in place with adhesive tape. The gauze pads were removed 4 hours following application, and each test site was scored individually for erythema and for edema using the Draize skin scoring scale as follows:
Erythema Formation
Very slight erythema (barely perceptible)
Well-defined erythema
Moderate to severe erythema
Severe erythema (beet redness) to slight eschar formation (injuries in depth)
Total possible erythema score = 4
1
2
3
4
Claims (10)
1. r 22 2 2 -13-Edema Formation Very slight edema (barely perceptible) 1 Slight edema (edges of area well defined by definite raising) 2 Moderate edema (area raised approximately 1 mm) 3 Severe edema (raised more than 1 nun 5 and extending beyond area of exposure) 4 Total possible edema score = 4 Total possible primary irritation score = 8 Test sites were then reexamined at 24 and 72 hours for the same parameters, and observations were continued 10 until all irritation had subsided or until irritation was confirmed to be irreversibleThe mean scores from the 2r4 and 72 hour gradings for each test group were then averaged to determine a primary irritation index (P.I.I.) The lower the score thus obtained, the less irritating is the 15 formulationA score of 5 or more indicates a primary dermal irritantThe results obtained with Formulations A, B and C expressed as Primary Irritation Indexes (P.I.I.), were as follows: 20 - Formulation P.I.IA 2.5 B 3.5 C 4.08 These results indicate that use of sodium benzoate with a quaternary ammonium halide in molar equivalent ratios of sodium benzoate to the quaternary halide from about 1:1 (Formulation B) to about 2:1 (Formulation A) produces significant diminution of skin irritancy over compositions formulated without sodium benzoate 3q (Formulation C) 222226. t 14 - comprising: formula: What we claim is: A liquid sanitizing and cleaning composition [: (A) a quaternary ammonium benzoate of the Ri r3 + X" R2 r4 I where R^ and R2 are lower-alkyl groups containing from 1 to 3 carbon atoms; R3 is Cs-C^ alkyl; is Cg-C^g alkyl or benzyl; and X~ is the benzoate anion; (3) a nonionic surfactant which is an alkylphenolethoxylate of the formula: where R is C8-Cg alkyl, and x is an integer from 7 to 13, or a straight-chain alkylethoxylate or secondary alkylethoxylate of the formula: K-(OCH2CH2)nOR5 III where R5 is Ci4-C15 alkyl and n is an integer from 7 to 13; (C) water; and (D) from 0 to 7 weight percent of an alkali metal benzoate; or said (A) quaternary ammonium benzoate is replaced by a corresponding quaternary ammonium halide of Formula I where X is a halide ion, and from one to two molar equivalents of said (D) alkali metal benzoate per mole of said (A) quaternary ammonium halide are present.
2. A composition according to claim 1, which comprises from 1 to 10 weight percent of the quaternary ammonium benzoate or halide of Formula I and from 10 to 20 weight percent of the nonionic surfactant. II ^NT< ft s8decv*» jSfc, - 15 - 222226
3. A composition according to claim 1 or 2, in which (B) is an alkylethoxylate of Formula III.
4. A composition according to any one of the preceding claims, comprising: (A) a quaternary ammonium halide of the formula: Ri ■*3 •N *2' *4 where R^_ and R2 are lower-alkyl groups containing from 1 to 3 carbon atoms; R3 is C8-C16 alkyl; R4 is Cg-C16 alkyl or benzyl; and X~ is a halide anion; (3) a nonionic surfactant which is an alkylphenolethoxylate of the formula: (OCH2CH2)X-OH II where R is CH3C(CK3)2CH2C(CH3)2- or a mixture of branched chain isomers of the formula CgH^g, and x is an integer from 7 to 13, or a straight-chain alkylethoxylate or secondary alkylethoxylate of the formula: H-(OCH2CH2)nOR5 III where R5 is C14-C3.5 alkyl and n is an integer from 7 to 13 ; (C) water; and (D) from one to two molar equivalents of an alkali metal benzoate relative to the quaternary ammonium halide of Formula I.
5. A composition according to claim 4, containing from 4 to 10 weight percent of the quaternary ammonium halide and from 12 to 17 weight percent of the alkylethoxylate.
6. A composition according to claim 5, containing about 6.4 weight percent of the quaternary ammonium halide and about 12 weight percent of the alkylethoxylate.
7. A composition according to claim 6, wherein - 8D&C1989 222226 - 16 - quaternary ammonium halide is dimethylalkylbenzylammonium chloride (50% C^, 40% C]_2 an<^ 10% C]_g alkyl) and the alkylethoxylate is pareth-45-7.
8. A composition according to any one of claims 4-7, which contains about 2 molar equivalents of sodium benzoate relative to the quaternary ammonium halide.
9. A composition according to any one of the preceding claims, which includes a brightener, a dye, a fragrance and/or a thickener.
10. A liquid sanitizing and cleaning composition according to any one of claims 1 to 9, substantially as herein described with reference to any one of the Examples. .ixife By^is/ihelr authorised Agents., A. j. PAP.-C & SON. Per . . j? ✓»» —<■
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92821186A | 1986-11-07 | 1986-11-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ222226A true NZ222226A (en) | 1990-01-29 |
Family
ID=25455890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ22222687A NZ222226A (en) | 1986-11-07 | 1987-10-20 | Liquid sanitising/cleaning compositions with quaternary ammonium, benzoate and nonionic surfactants |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS63165500A (en) |
AU (1) | AU605795B2 (en) |
NZ (1) | NZ222226A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8625103D0 (en) * | 1986-10-20 | 1986-11-26 | Unilever Plc | Disinfectant compositions |
-
1987
- 1987-10-20 NZ NZ22222687A patent/NZ222226A/en unknown
- 1987-10-30 AU AU80532/87A patent/AU605795B2/en not_active Ceased
- 1987-11-02 JP JP27815387A patent/JPS63165500A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU8053287A (en) | 1988-05-12 |
JPS63165500A (en) | 1988-07-08 |
AU605795B2 (en) | 1991-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4069347A (en) | Compositions of quaternary ammonium derivatives of lanolin acids | |
US4769169A (en) | Amphoteric surfactants for use in antimicrobial cleaning compositions | |
US4186113A (en) | Low irritating detergent compositions | |
CA1131096A (en) | Detergent compositions | |
CA1091157A (en) | Alkyleneoxylated bisquaternary ammonium with anionic or amphoteric detergent | |
US4372869A (en) | Detergent compositions | |
US4303543A (en) | Method for cleansing and conditioning the skin | |
US4235759A (en) | Liquid detergent compositions | |
US4369134A (en) | Creamy cleansing compositions | |
CA1333691C (en) | Two phase cleansing, conditioning and medicinal treatment shampoo | |
NO802408L (en) | SOLUTION COMPOUNDS. | |
CA1132027A (en) | Detergent compositions | |
US4891214A (en) | Particulate emulsifiable hair conditioning composition | |
US5858936A (en) | Detergent composition | |
US4804492A (en) | Liquid sanitizing and cleaning compositions with diminished skin irritancy | |
US4049665A (en) | Unsymmetrical disulfides as antimicrobial agents | |
GB1496102A (en) | Transparent liquid shampoo | |
US4534877A (en) | Shampoo compositions comprising specific betaine surfactants and a quaternary compound | |
US4636329A (en) | Shampoo compositions comprising quaternary imidazolinium compound and alkylamido betaine having low pH range | |
US4231903A (en) | Detergent compositions | |
FI80013B (en) | TVAETTMEDELSFOERENINGAR OCH - KOMPOSITIONER. | |
FI67723C (en) | TVAETTMEDELKOMPOSITION INNEHAOLLANDE AMPHOTERISKT FETTSYRAKOMPLEX | |
EP0067635A2 (en) | Shampoo compositions | |
US4261851A (en) | Low-irritating detergent composition | |
AU605795B2 (en) | Liquid sanitizing and cleaning composition |